RESTRICION FRAGMENT LENGTH POLYMORPHISM ANALYSIS OF JORDANIAN FIELD STRAINS OF INFECTIOUS BURSAL DISEASE VIRUS

Document Type : Research article

Author

Dept. of Pathology and Animal Health Fac. Vet. Med., Jordan Uni. of Sci. & Technology

Abstract

Reverse transcriptase-polymerase chain reaction/ restriction fragment length polymorphism (RT-PCR/RFLP) techniques were used for the preliminary characterization of Jordanian field strains of Infectious Bursal Disease Viruses (IBDVs). Bursal samples from 18 field outbreaks in commercial and backyard chicken flocks with typical signs of IBD and high mortality (20%-60%) rate were examined, however the internal positive control could be amplified from only 6 samples. Four of these 6 samples were positive by RT-PCR that amplified the 743-bp region of the VP2 gene of IBDV. Following digestion with BstNI, MboI, and Ssp < /em>I restriction enzymes, three different RT-PCR/RFLP profiles were detected. Strain number 10 has RFLP profiles consistent with those of the Middle Eastern vvIBDV and can be designated to molecular group 6. Strains numbered 5 and 12 can be classified into molecular group 3. These viruses have RFLP profiles similar to the USA classic strain (2512) which is widely in use as a vaccine strain and is also Ssp < /em>I positive. The RFLP profile generated for strain number 2 was not consistent with the available profiles for the molecular groupings and using the described assays, this virus was not able to be classified. The detection of strain number 2 may requires further nucleotide and amino acid sequence analysis to completely characterize this strain. The identification of an IBDV strain number 10 with an RELP profile consistent with those most frequently  observed for vvIBDV strains  is of major concern and demands further research attention  to determine its prevalence within Jordan

Keywords


Dept. of Pathology and Animal Health

Fac. Vet. Med., Jordan Uni. of Sci. & Technology 

 

RESTRICION FRAGMENT LENGTH POLYMORPHISM ANALYSIS OF JORDANIAN FIELD STRAINS OF INFECTIOUS BURSAL DISEASE VIRUS

(With One Table and 2 Figures)

 

By

M.Q. AL-Natour

(Received at 29/12/2005)

 

تقنية  RFLPلدراسة العترات (المعزولات)الاردنية الحقلية لفيروس مرض غدة فايبريشيا المعدي (الجمبورو)

 

محمد الناطور

 

استخدمت تقنية RT-PCR/RFLP لدراسة الصفات الاوليه للفيروسات الحقلية الاردنية المسببه لمرض التهاب غدة فايبريشيا الفيروسي. فحصت عينات الغدد ((Bursas والتي جمعت من ثمانية عشر حقلا مصابا او من الدجاج المربى منزلياً والذي ظهرت عليه الأعراض النموذجية للمرض وتميز باحداث نسب نفوق عاليه تراوحت بين 20-60 %. امکن مضاعفة السيطرة الموجبه الداخلية (IC) من ستة عينات فقط، کانت أربعة من العينات السته موجبة لاختبار  RT/PCRوالذي ضاعف منطقة 743-bp في جين VP2 للفيروس. تم تحديد  ثلاثة اشکال من RT-PCR/RFLP بعد استخدام الانزيمات المحددة BstNI،MboI، .SsPI تبين أن العتره الفيروسية رقم عشره کان لها شکل مطابق للفيروس الشرق اوسطي شديد الضراوة ، ويمکن أن تکون ضمن المجموعة الجزيئية السادسة. اما العترتان الخامسة و الثانية عشر يکون تصنيفهما ضمن المجموعة الجزيئية الثالثة. هذه الفيروسات لها اشکال RFLP مشابه للعترة الامريکية التقليدية 2512 والتي تستخدم على نطاق واسع کعترة لقاح اضافة الى انها موجبه  .SspIان شکل RFLP الذي تکون للعترة الثانية لم يکن متناسقا مع الاشکال المتوفره للمجاميع الجزيئية ولا يمکن تصنيف هذا الفيروس باستخدام طرق التشخيص الموصوفة. ان تشخيص العترة العاشرة لفيروس غدة فايبريشيا والتي لها شکل RFLP مطابقا لما يمکن ملاحظته غالبا لعترة فيروس مرض التهاب غدة فيبريشى الشديد الأمراضية ذا شان عظيم ويستحق العنايه بدراسات اخرى لغرض توصيفه کاملا للوقوف على مدى انتشاره في الاردن.

 

SUMMARY

 

Reverse transcriptase-polymerase chain reaction/ restriction fragment length polymorphism (RT-PCR/RFLP) techniques were used for the preliminary characterization of Jordanian field strains of Infectious Bursal Disease Viruses (IBDVs). Bursal samples from 18 field outbreaks in commercial and backyard chicken flocks with typical signs of IBD and high mortality (20%-60%) rate were examined, however the internal positive control could be amplified from only 6 samples. Four of these 6 samples were positive by RT-PCR that amplified the 743-bp region of the VP2 gene of IBDV. Following digestion with BstNI, MboI, and SspI restriction enzymes, three different RT-PCR/RFLP profiles were detected. Strain number 10 has RFLP profiles consistent with those of the Middle Eastern vvIBDV and can be designated to molecular group 6. Strains numbered 5 and 12 can be classified into molecular group 3. These viruses have RFLP profiles similar to the USA classic strain (2512) which is widely in use as a vaccine strain and is also SspI positive. The RFLP profile generated for strain number 2 was not consistent with the available profiles for the molecular groupings and using the described assays, this virus was not able to be classified. The detection of strain number 2 may requires further nucleotide and amino acid sequence analysis to completely characterize this strain. The identification of an IBDV strain number 10 with an RELP profile consistent with those most frequently  observed for vvIBDV strains  is of major concern and demands further research attention  to determine its prevalence within Jordan

 

Key words: Infectious Bursal Disease Virus, RFLP, VP2, vvIBDV, Chicken, Jordan.

 

INTRODUCTION

 

Infectious bursal disease virus (IBDV) of the Birnaviridae family is a double-stranded RNA virus with bisegmented genome (Muller, et al., 1979). It is the causative agent of an acute, highly contagious, and immunosuppressive disease in young chickens known as infectious bursal disease “IBD” (Saif, 1991). Of the two distinct viral serotypes, only serotype 1 viruses are able to cause the disease in poultry (Jackwood, et al., 1985; Ismail, et al., 1988). At least six antigenic subtypes of serotype I IBD viruses have been identified by in-vitro cross-neutralization (VN) assay (Jackwood and Saif, 1987). The commonly known variant viruses are in one of these antigenic subtypes and classic viruses are in another antigenic subtype. In the mid eighties very virulent IBDV (vvIBD) was recognized from acute cases of IBD in Europe (Chettle, et al., 1989). Since then, vvIBDV has been isolated in many countries in Europe, Asia, the Middle East, and Latin America (Nunoya, et al., 1992; Lin, et al., 1993; Cao, et al.,1998; Ture, et al., 1998: Di Fabio, et al.,1999; Eterradossi, et al., 1999; Abdel-Alim, et al., 2003; Banda, et al., 2003). High levels of maternally derived antibodies can protect chicks against wild type virus challenge but also depends on the IBDV strain used in the parent flock vaccination program and the circulating wild type viruses (Al-Natour, et al., 2004). These vvIBDV strains are able to break through high levels of maternally derived antibodies in commercial flocks causing high mortality rates up to 60%-100% (Eterradossi, et al., 1992).

Reverse transcriptase-polymerase chain reaction (RT-PCR) and restriction fragment length polymorphism (RFLP) have been used to identify the restriction enzyme markers SspI, BstNI and MboI within the VP2 hyper variable region. These restriction markers were used toplace IBDV strains into 6 broad molecular groups (Jackwood and Sommer, 1997; Jackwood and Sommer1998; Jackwood and Sommer, 1999). Jackwood and Sommer (1997) reported that the RT-PCR/RFLP analysis was an improvement over the RT-PCR-restriction enzyme (RE) assay because it examines a large portion of the VP2 gene (743 bp) for the presence of multiple restriction sites of BstNI and MboI enzymes.

The SspI enzyme site in a 743-bp RT-PCR fragment of VP2 has been found to be present in many viruses designated with a vvIBDV phenotype (Lin, et al., 1993; Ture, et al., 1998; Jackwood and Sommer, 1999). However some workers detected this RE site in viruses other than vvIBDV (Cao et al., 1998; Banda et al., 2001; Hoque et al., 2001). Typically, the vvIBDV strains exhibit RELP patters characteristic of molecular group 6 with the presence of the SspI site and correlating description of severe clinical disease with high mortality rates (Abdel-Alim et al., 2003).

Ture, et al., ( 1998), reported the use of three restriction enzymes (BstNI, MboI, and SspI) in the RT-PCR/RFLP assay to characterize and compare five vvIBDVs from Turkey, Holland, and Taiwan with U.S. serotype 1 classic (STC) and variants (Maryland, Indiana) and serotype 2 (Ohio) viruses. When digested with BstNI the RFLP profiles of the five vvIBDV isolates were different from the U.S. STC strain but were similar to the variant viruses (Maryland, Indiana). When digested with MboI the RFLP profiles for the isolates from Holland and Turkey were similar to the STC strains but were different from the variant viruses. When the two Taiwanese isolates were digested with MboI the RFLP profiles of these isolates were different from the Holland and Turkey strains, and the U.S. classic and variant viruses.

In Jordan disease due to IBD virus is widespread in the poultry industry (Anon, 2000). Severe outbreaks of IBDV with high rates of mortality (20-60%) in vaccinated flocks have been noted (Al-Natour unpublished observation). In light of the current situation in Jordan, the objective of this study was to undertake molecular typing of Jordanian IBDV field strains that caused severe outbreaks in broiler, layer and backyard flocks using RT-PCR/RFLP.

 

MATERIALS and METHODS

 

Bursal samples and RNA preparation:

Five bursal samples from each of the 18 field outbreaks in commercially reared broiler flocks (2-6 weeks of age), one layer flock  (6 weeks of age) and one-backyard flock (8 weeks of age) with typical IBD signs were examined. The IBD virus was inactivated in a solution of phenol: chloroform: isoamyl alcohol (25:24:1 [v/v]) and shipped to the United States, (Jackwood, et al., 1996). The samples were then rinsed in 10 volumes of TNE buffer (10 mM Tris-HCL, pH 8.0,          100 mM NaCl, 1 mM ethylenediaminetetraacetic acid), homogenized in TNE buffer, chloroform extracted and proteinase K (Sigma Chemical Co., St. Louis, MO) digested at a final concentration of 1.0 mg/ml, in 0.5% (w/v) of sodium duodecyl sulfate (Sigma). RNA was extracted by separation in acid phenol, pH 4.3 (Amresco, Solon, OH) followed by chloroform:isoamyl alcohol (24:1), and then ethanol precipitated from the aqueous phase. The RNA was resuspended in 100μl of 90% dimethyl sulfoxide (DMSO) as described by Jackwood and Sommer, (1997).

RT/PCR-RFLP:

The procedure was based on that described by (Jackwood and Nielsen, 1997; Jackwood and Sommer, 1997). Two μl of viral RNA was amplified using the GeneAmp RNA PCR kit (Perkin Elmer, Roche Molecular System, Inc., Branchburg, NJ) according to the instructions of the manufacturer. The RNA was denatured at 95°C for 5 minutes then reverse transcribed at 42°C for 1 hr. Products were amplified under the following conditions; 95°C for 5 min, 52°C for 1.0 min, and 72°C for 1.0 min. The 700-5’ and 700-3’ primers were used to amplify a 743-bp fragment of the VP2 gene from 710 bp to 1444 bp (Jackwood and Nielsen, 1997). The ssRNA internal control (IC) reagent (Smiley, et al., 1999) that amplifies the 900 bp fragment was added. The PCR product was digested with the restriction enzymes BstNI, MboI and SspI (Lin,   et al., 1993) and a 2.5% MetaPhor agarose gel (FMC Bio-Products, Rockland, ME) with SYBER TM green I nucleic acid gel stain (Molecular Probes, Inc., Eugene, OR) was used to detect the restriction fragments. A100-bp DNA size marker was included on each agarose gel (Jackwood and Sommer, 1997). 

 

RESULTS

 

RT-PCR:

Four (2/16 broiler, 1/1 layer and 1/1 backyard flocks) out of the 6 bursal samples in which the internal positive control could be amplified were determined to have IBDV RNA as evidenced by amplification of a 743-bp region of the VP2 gene by the RT-PCR. The positive samples were obtained from flock number 2, 5, 10 and 12 as shown in Fig. 1. Digestion of the RT-PCR products of these viruses with three restriction enzymes BstNI, MboI or SspI showed different RFLP profiles as shown in Fig. 2 and  summarized in Table 1.

Digestion of the RT-PCR products with MboI restriction enzyme:

When using MboI enzyme for digestion of the RT-PCR products of these isolates, three different RFLP profiles were detected. The first profile was detected in the sample obtained from flock number 2 (flock number will be used to identify the virus) that generated three fragments with sizes consistent with a pattern of 170 bp, 229 bp, and 362 bp (Fig. 2 Lane 6). The second profile was seen in two samples (numbers 5 and 12) that generated two fragments with sizes consistent with a pattern of 229 bp and 403 bp (Fig. 2 Lane 7 and 12). The third profile was detected in sample number 10 that generated two fragments with sizes of 229 bp and 362 bp (Fig. 2 Lane 8).

Digestion of the RT-PCR products with BstNI restriction enzyme:

After digestion of the RT-PCR products of these viruses with BstNI enzyme two viruses (numbers 2 and 10) had identical RFLP profiles that generated three fragments with sizes consistent with a pattern of 119 bp, 172 bp, and 424 bp. (Fig. 2 lanes 1 and 3). The RFLP profile of viruses (numbers 5 and 12) were identical and each yielded four fragments sizes consistent with a pattern of 119 bp, 139 bp, 154 bp and 172 bp (Fig. 2 lane 2 and 4).

Digestion of the RT-PCR products with SspI restriction enzyme:

All the detected viruses (numbers 2, 5, 10, and 12) were SspI enzyme positive and each yielded two fragments approximately 273 bp and 470 bp in size (Fig. 2 lanes 11-14 and Table 1).

 

Table 1: RT-PCR/RFLP results for the Jordanian infectious bursal disease virus strainsA.

 

Flock no.

Principal breed

RT-PCR

results

SspIB

BstNI enzyme

MboI enzyme

1

Broiler

Negative

-

 

 

2

Broiler

Positive

+

119 bp, 172 bp, 424 bp

170 bp, 229 bp, 362bp

5

Broiler

Positive

+

119 bp, 139bp, 154bp, 172 bp

229 bp, 403bp

10

Backyard

Positive

+

119 bp, 172 bp, 424 bp

229 bp, 362 bp

12

Layer

Positive

+

119 bp, 139 bp, 154 bp, 172 bp

229 bp, 403 bp

15

Broiler

Negative

-

 

 

 

A Values are the length in base pair of the restriction fragments. BPresence of  SspI restriction site.RT-PCR = reverse transcriptase- polymerase chain reaction. RFLP = restriction fragment length polymorphism.  All flocks were vaccinated once or twice with an intermediate plus IBDV vaccine in this area according to the manufacturer’s recommendations except flock number 2 and 10.

 

 

 

 

Fig. 1: RT/PCR products of the Jordanian field IBDV isolates. The PCR products were separated into a 2.5% agarose gel, and a 743-bp fragment was observed in the positive lanes. The IC (900 bp) reaction products are shown. The 100-bp ladder (Gibco, BRL Gaithersburg, MD) was used as a molecular weight marker (M).

 

 

 

Fig. 2: RFLPs observed when MboI, BstNI and SsPI enzymes were used. Lanes designated M contain the 100-bp ladder molecular weight marker.

 

DISCUSSION

 

In this study the bursal samples were collected from 18 outbreaks that had clinical signs and lesions of IBD however only 6 generated the expected 900 bp band by RT-PCR corresponding to the internal positive control. These results indicate either RNA degradation during preparation and storage of the samples or inhibition of the RT-PCR reaction by contaminants in a large proportion of the samples. Of the 6 samples positive for the internal control 4 bursal samples were determined to contain IBDV as evidenced by positive RT-PCR reaction.

When the RT-PCR products of the four detected isolates of IBDV were digested with MboI and BstNI restriction enzymes, three different RFLP profiles were generated. The RFLP profile of virus number 10 (backyard flock) yielded two fragments with sizes of 229 bp and 362 bp when digested with MboI enzyme and three fragments with sizes of 119bp, 172bp and 424bp when digested with BstNI enzyme.  This RFLP profile resembles the RFLP profile of the previously published Dutch, Turkish and Egyptian vvIBDV (Ture, et al., 1998; Eterradossi, et al., 1999; Abdel-Alim, et al., 2003). Viruses number 5 (Broiler flock) and number 12 (Layer flock) were similar. In both viruses the RFLP profile yielded two fragments of 229 bp and 403 bp in size when digested with MboI enzyme and four fragments of 119bp, 139bp, 154bp and 172bp after digestion with BstNI enzyme. These two viruses with identical patterns are similar to the US (26th egg passage) 2512 strains and the US IBD BLINTM vaccine strain of the classic serotype 1 IBDV. (D.J. Jackwood personal communication). Virus number 2 (Broiler flock) generated RFLP profile with three fragment sizes of 119bp, 172bp and 424bp when digested with BstNI enzyme which is similar to virus number 10, and when digested with the MboI enzyme the RFLP profile of this virus produced three fragments with sizes of 170bp, 229bp, and 362bp. The presence of an additional 170 bp band in the RFLP pattern does not resemble any previously published IBDV RFLP profiles (Jackwood and Nielsen, 1997; Jackwood and Sommer, 1998; Ture, et al., 1998; Jackwood and Sommer, 1999; Abdel-Alim and Saif, 2001; Abdel-Alim, et al., 2003).

  Of the four viruses detected all were SspI positive. Most commonly vvIBDV strains have RFLP profiles characterized as molecular group 6 combined with the SspI marker. These features are present for virus number 10 and therefore are consistent with the most frequently identified RFLP profiles of vvIBDV strains. Conclusive identification of strain number 2 as vvIBDV will require further sequence analysis.

  From this study, it is concluded that 4 Jordanian IIBDV RFLP profiles were identified. Strain number 10 has RFLP profiles consistent with those of the Middle Eastern vvIBDV and can be designated to molecular group 6. Strains numbered 5 and 12 can be classified into molecular group 3. These viruses have RFLP profiles similar to the US classic strain (2512) which is widely in use as a vaccine strain and is also SspI positive. The RFLP profile generated for strain number 2 was not consistent with the available profiles for the molecular groupings and using the described assays, this virus was not able to be classified. This strain could be addressed by further nucleotide and amino acid sequence analysis.

            In the Middle East and Europe vvIBDV strains have been reported to break through high levels of maternal antibodies in commercial flocks, causing up to 60%–100% mortality rates in chickens and producing lesion typical of IBDV (Eterradossi, et al., 1992). Therefore, the identification of an IBDV strain number 10 with an RFLP profile consistent with those most frequently observed for vvIBDV strains is a major concern and demands further research attention to determine its prevalence within Jordan.

 

Acknowledgments

 

The author thanks Dr. Y. M. Saif , Dr. D. J. Jackwood and Dr. M. Peters for reviewing this manuscript. Thanks to Dr. Saif for using the FAHRP laboratories at Wooster Ohio, USA, providing technical advice. Also, thanks Ms. Susan Sommer and Dr. Gomma Abdel-Alim for technical assistance. This work received financial support from the Deanship of Research, Jordan University of Science and Technology, project number 52/98, and from the MERC USAID fund project.  

Running Head: RFLP analysis of Jordanian Field Strains of IBDV

Abbreviations: bp = base pair; DMSO = dimethyl sulfoxide; IBDV = infectious bursal disease virus; IC = internal control; RE = restriction enzyme; 2512 strain = (26th egg passage) USA serotype 1 classic; TNE buffer = 10mM Tris-HCl, pH 8.0, 100mM NaCl, 1mM. TNE = Tris-sodium chloride and EDTA buffer, IBD= infectious bursal disease, vvIBDV = very virulent infectious bursal disease virus, RFLP = restriction fragment length polymorphism, RT-PCR = reverse transcription-polymerase chain reaction, VN = virus neutralization.

 

REFERENCES

 

Abdel-Alim, G.A.; Awaad, M.H. and Saif, Y.M. (2003): Characterization of Egyptian field strains of infectious bursal disease virus: Avian Dis. 47, 1452-1457.

Abdel-Alim, G.A., and Saif, Y.M. (2001): Immunogenicity and antigenicity of very virulent strains of infectious bursal disease viruses: Avian Dis. 45, 92–101.

Al-Natour, M.Q.; Ward, L.A.; Saif, Y.M.; Stewart-Brown, B. and Keck, L.D. (2004): Effect of different levels of maternally derived antibodies on protection against infectious bursal disease virus. Avian Dis. 48, 117-182.

Anon, (2000): Annual Report. Ministry of Agriculture, Jordan. 1-63.

Banda, A.; Villegas, P.; El-Attrache, J. and Estevez, C. (2001): Molecular characterization of seven field isolates of infectious bursal disease virus obtained from commercial broiler chicken. Avain Dis., 47: 67 – 95.

Banda, A.; Villegas, P.; and El-Attrache, J. (2003): Molecular characterization of infectious bursal disease virus from commercial poultry in the United States and Latin Ameica. Avian Dis., 47:67-95.

Cao, Y.C.; Yeung, W.S.; Law, M.; Bi, Y.Z.; Leung, F.C. and Lim, B.L. (1998): Molecular characterization of seven Chinese isolates of infectious bursal disease virus: classical, very virulent, and variant strains: Avian Dis. 42, 340–351.

Chettle, N.J.; Stuart, C. and Wyeth, P.J. (1989): Outbreak of virulent IBD in East Anglia: Vet. Rec. 125, 271–272.

Di Fabio, J.; Rossini, L.I.; Eterradossi, N.; Toquin, D. and Gardin, Y. (1999) : European-like pathogenic infectious bursal disease viruses in Brazil: Vet. Rec. 145, 203–204.

Eterradossi, N.; Picault, J.P.; Drouin, P.; Guittle, M.; L'Hospitalier, R. and Bennejean, G. (1992): Pathogenicity and preliminary antigenic characterization of six infectious bursal disease virus strains isolated in France from acute outbreaks: J. Vet. Med. B. 39, 683–691.

Eterradossi, N.; Arnaud, C.; Tekaia, F.; Toquin, D.; le Cog, H.; Rivallan, G.; Guitte, M.; Domenech, J.; Van den Berg, T.P. and Skinner, M.A. (1999): Antigenic and genetic relationship between European very virulent infectious bursal disease viruses and an early West-African isolate: Avian Pathol. 28, 36–46.

Hoque, M.M.; Omar, A.R.; Chong, L.K.; Hair-Bejo, M. and Aini, I. (2001): Pathogenecity of SspI-positive infectious bursal disease virus and molecular characterization of VP2 hypervariable region. Avain Pathol. 30: 369-380.

Ismail, N.M.; Saif, Y.M. and Moorhead, P.D. (1988): Lack of pathogenicity of five serotype 2 infectious bursal disease viruses in chickens: Avian Dis. 32, 757–759. 

Jackwood, D.J.; Saif, Y.M. and Moorhead, P.D. (1985): Immunogenicity and antigenicity of infectious bursal disease virus serotype I and II in chickens: Avian Dis. 29, 1184–1194.

 Jackwood, D.J. and Saif, Y.M. (1987): Antigenic diversity of infectious bursal disease viruses: Avian Dis. 31, 766–770.

Jackwood, D.J.; Hanes, G. and Hiens Miller, S. (1996): Infectious bursal disease viral RNA can be amplified using RT/PCR from bursa tissue following inactivation of the virus with phenol:chloroform: Avian Dis. 40, 457–460.

Jackwood, D.J. and Nielsen, C.K. (1997): Detection of infectious bursal disease viruses in commercially reared chickens using the reverse transcription polymerase chain reaction-restriction endonuclease assay: Avian Dis. 41, 137–143.

Jackwood, D.J. and Sommer, S.E. (1997): Restriction fragment length polymorphism in the VP2 gene of infectious bursal disease virus: Avian Dis. 41, 627–636.

Jackwood, D.J. and Sommer, S.E. (1998): Genetic heterogeneity in the VP2 gene of infectious bursal disease viruses detected in commercially reared chickens: Avian Dis. 42, 321–339.

Jackwood, D.J. and Sommer, S.E. (1999): Restriction fragment length polymorphism in the VP2 gene of infectious bursal disease viruses from outside the United States: Avian Dis. 43, 310–314.

Lin, Z.; Kato, A.; Otaki, Y.; Nakamura, T.; Sasmz, E. and Ueda, S. (1993): Sequence comparisons of a highly virulent infectious bursal disease virus prevalent in Japan: Avian Dis. 37, 315–323.

Muller, H.; Scholtissek, C. and Becht, H. (1979): The genome of infectious bursal disease virus consists of two segments of double-stranded RNA: J. Virol. 31, 584–589.

Nunoya, T., Otaki, Y.; Tajima, M.; Hiraga, M. and Saito, T. (1992): Occurrence of acute infectious bursal disease with high mortality in Japan and pathogenicity of field isolates in specific-pathogen-free chickens: Avian Dis. 36, 597–609.

Saif, Y.M. (1991): Immunosuppression induced by infectious bursal disease virus: Vet. Immunol. Immunopathol. 30, 45–50.

Smiley, J.R.; Sommer, S.E. and Jackwood, D.J. (1999): Development of a ssRNA internal control reagent for an infectious bursal disease virus reverse transcription/polymerase chain reaction-restriction fragment length polymorphism diagnostic assay: J. Vet. Diagn. Invest. 11, 497–504.

Ture, O.; Saif, Y.M. and Jackwood, D.J. (1998): Restriction fragment length polymorphism analysis of highly virulent strains of infectious bursal disease virus from Holland, Turkey, and Taiwan: Avian Dis. 42, 470–479.

REFERENCES
 
Abdel-Alim, G.A.; Awaad, M.H. and Saif, Y.M. (2003): Characterization of Egyptian field strains of infectious bursal disease virus: Avian Dis. 47, 1452-1457.
Abdel-Alim, G.A., and Saif, Y.M. (2001): Immunogenicity and antigenicity of very virulent strains of infectious bursal disease viruses: Avian Dis. 45, 92–101.
Al-Natour, M.Q.; Ward, L.A.; Saif, Y.M.; Stewart-Brown, B. and Keck, L.D. (2004): Effect of different levels of maternally derived antibodies on protection against infectious bursal disease virus. Avian Dis. 48, 117-182.
Anon, (2000): Annual Report. Ministry of Agriculture, Jordan. 1-63.
Banda, A.; Villegas, P.; El-Attrache, J. and Estevez, C. (2001): Molecular characterization of seven field isolates of infectious bursal disease virus obtained from commercial broiler chicken. Avain Dis., 47: 67 – 95.
Banda, A.; Villegas, P.; and El-Attrache, J. (2003): Molecular characterization of infectious bursal disease virus from commercial poultry in the United States and Latin Ameica. Avian Dis., 47:67-95.
Cao, Y.C.; Yeung, W.S.; Law, M.; Bi, Y.Z.; Leung, F.C. and Lim, B.L. (1998): Molecular characterization of seven Chinese isolates of infectious bursal disease virus: classical, very virulent, and variant strains: Avian Dis. 42, 340–351.
Chettle, N.J.; Stuart, C. and Wyeth, P.J. (1989): Outbreak of virulent IBD in East Anglia: Vet. Rec. 125, 271–272.
Di Fabio, J.; Rossini, L.I.; Eterradossi, N.; Toquin, D. and Gardin, Y. (1999) : European-like pathogenic infectious bursal disease viruses in Brazil: Vet. Rec. 145, 203–204.
Eterradossi, N.; Picault, J.P.; Drouin, P.; Guittle, M.; L'Hospitalier, R. and Bennejean, G. (1992): Pathogenicity and preliminary antigenic characterization of six infectious bursal disease virus strains isolated in France from acute outbreaks: J. Vet. Med. B. 39, 683–691.
Eterradossi, N.; Arnaud, C.; Tekaia, F.; Toquin, D.; le Cog, H.; Rivallan, G.; Guitte, M.; Domenech, J.; Van den Berg, T.P. and Skinner, M.A. (1999): Antigenic and genetic relationship between European very virulent infectious bursal disease viruses and an early West-African isolate: Avian Pathol. 28, 36–46.
Hoque, M.M.; Omar, A.R.; Chong, L.K.; Hair-Bejo, M. and Aini, I. (2001): Pathogenecity of SspI-positive infectious bursal disease virus and molecular characterization of VP2 hypervariable region. Avain Pathol. 30: 369-380.
Ismail, N.M.; Saif, Y.M. and Moorhead, P.D. (1988): Lack of pathogenicity of five serotype 2 infectious bursal disease viruses in chickens: Avian Dis. 32, 757–759. 
Jackwood, D.J.; Saif, Y.M. and Moorhead, P.D. (1985): Immunogenicity and antigenicity of infectious bursal disease virus serotype I and II in chickens: Avian Dis. 29, 1184–1194.
 Jackwood, D.J. and Saif, Y.M. (1987): Antigenic diversity of infectious bursal disease viruses: Avian Dis. 31, 766–770.
Jackwood, D.J.; Hanes, G. and Hiens Miller, S. (1996): Infectious bursal disease viral RNA can be amplified using RT/PCR from bursa tissue following inactivation of the virus with phenol:chloroform: Avian Dis. 40, 457–460.
Jackwood, D.J. and Nielsen, C.K. (1997): Detection of infectious bursal disease viruses in commercially reared chickens using the reverse transcription polymerase chain reaction-restriction endonuclease assay: Avian Dis. 41, 137–143.
Jackwood, D.J. and Sommer, S.E. (1997): Restriction fragment length polymorphism in the VP2 gene of infectious bursal disease virus: Avian Dis. 41, 627–636.
Jackwood, D.J. and Sommer, S.E. (1998): Genetic heterogeneity in the VP2 gene of infectious bursal disease viruses detected in commercially reared chickens: Avian Dis. 42, 321–339.
Jackwood, D.J. and Sommer, S.E. (1999): Restriction fragment length polymorphism in the VP2 gene of infectious bursal disease viruses from outside the United States: Avian Dis. 43, 310–314.
Lin, Z.; Kato, A.; Otaki, Y.; Nakamura, T.; Sasmz, E. and Ueda, S. (1993): Sequence comparisons of a highly virulent infectious bursal disease virus prevalent in Japan: Avian Dis. 37, 315–323.
Muller, H.; Scholtissek, C. and Becht, H. (1979): The genome of infectious bursal disease virus consists of two segments of double-stranded RNA: J. Virol. 31, 584–589.
Nunoya, T., Otaki, Y.; Tajima, M.; Hiraga, M. and Saito, T. (1992): Occurrence of acute infectious bursal disease with high mortality in Japan and pathogenicity of field isolates in specific-pathogen-free chickens: Avian Dis. 36, 597–609.
Saif, Y.M. (1991): Immunosuppression induced by infectious bursal disease virus: Vet. Immunol. Immunopathol. 30, 45–50.
Smiley, J.R.; Sommer, S.E. and Jackwood, D.J. (1999): Development of a ssRNA internal control reagent for an infectious bursal disease virus reverse transcription/polymerase chain reaction-restriction fragment length polymorphism diagnostic assay: J. Vet. Diagn. Invest. 11, 497–504.
Ture, O.; Saif, Y.M. and Jackwood, D.J. (1998): Restriction fragment length polymorphism analysis of highly virulent strains of infectious bursal disease virus from Holland, Turkey, and Taiwan: Avian Dis. 42, 470–479.